Altered serum total sialic acid, lipid peroxidation, ceruloplasmin and glutathione reductase levels in patients with carcinoma of prostate

Journal of Clinical and Diagnostic Research

Volumn 3, Issue 2, 2009, Pages 1483-1485

  Surapaneni, Krishna Mohan ^a   Vishnu Priya, V ^b  

^a SAVEETHA MEDICAL COLLEGE AND HOSPITAL   (India)

^b SAVEETHA UNIVERSITY   (India)

Author keywords

Ceruloplasmin; Glutathione reductase; Malondialdehyde (MDA); Prostate cancer; Sialic acid

Indexed keywords

CERULOPLASMIN; GLUTATHIONE REDUCTASE; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; SIALIC ACID;

ANTIOXIDANT ACTIVITY; BLOOD LEVEL; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; LETTER; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PROSTATE CARCINOMA;

EID: 70549113405     PISSN: None     EISSN: 0973709X     Source Type: Journal    
DOI: None     Document Type: Letter

References (14)

1. T Malati, G Rajani Kumari, PVLN Murthy, Ch Ram Reddy, B Surya Prakash. Prostate specific antigen in patients of benign prostate hypertrophy and carcinoma of prostate. Ind J Clin Biochem. 2006; 21 (1): 34-40.
2. Ponnio M., Alho H., Nikkari S.T., Olsson U., Ryderberg U and Sillanaukee P. Serum Sialic acid in a random sample of the general population. Clin Chem 1999; 45: 1842-1849 (Pubitemid 29477344)
3. Iijima R., Takahashi H., Namme R., Ikegami S and Yamazaki M. Novel biological function of Sialic acid as a hydrogen peroxide scavenger. FEBS. Letters. 2004; 561: 163-166
4. Almushatat AS, Talwar D, Mc Ardle PA, Williamso C, Sattar N, O'Reilly DS, Underwood MA, Mc Milan DC. Vitamin antioxidants, lipid peroxidation and the systemic inflammatory response in patients with prostate cancer. Int J Cancer. 2006 Feb; 118 (4): 1051-1053 (Pubitemid 43157684)
5. Surapaneni K M, Venkata GR. Lipid peroxidation and antioxidant status in patients with carcinoma of prostate. Indian J Physiol Pharmacol. 2006 Oct-Dec; 50 (4): 350-354 (Pubitemid 44776176)
6. Warren L. The thiobarbituric acid assay of Sialic acids. J Biol Chem 1959; 234: 1971-1975
7. Satoh K. Serum lipid peroxide in cerebrovascular disorder determined by new colorimetric method. Clin Chim Acta 1978; 90: 37-43. (Pubitemid 9055456)
8. Ravin H.A. An improved colorimetric enzymatic assay for ceruloplasmin. J. Lab. Clin. Med. 1961; 58: 161-168
9. rd edn. 1983; Volume 3: p258-65.
10. Dobru-Abbasoglu S, Aykac-Toker G, Kocak T, Unluer E, Uysal M. Antixoidant enzyme activities and lipid peroxides in the plasma of patients with benign prostate hyperplasia or prostate cancer are not predictive. J Cancer Res Clin Oncol. 1999 Jul; 125 (7): 402-404 (Pubitemid 29287498)
11. Tanaka K., Tokumaru S and Kojo S. Possible involvement of radical reactions in desialylation of LDL. Febs. Lett. 1997; 413: 202-224
12. Hobarth K, Hofbauer J, Fang-Kircher S. Plasma Sialic acid in patients with prostate cancer. British Journal of Urology. 1993; 72: 621-624 (Pubitemid 23357189)
13. Surapaneni KM and Venkata GR. Erythrocyte ascorbic acid and plasma vitamin Estatus in patients with carcinoma of prostate. Indian J Physiol Pharmacol. 2007; 51 (2): 199-202.
14. Nayak SB, Bhat VR, Upadhyay D, Udupa SL. Copper and ceruloplasmin status in serum of prostate and colon cancer patients. Indian J Physiol Pharmacol. 2003 Jan; 47 (1): 108-110 (Pubitemid 36025627)